E

Eton Pharmaceuticals

ETON

3.58000
USD
-0.06
(-1.65%)
Market Closed
Volume
2,906
EPS
0
Div Yield
0
P/E
-33
Market Cap
222,708,078
Related Instruments
A
AIHS
-0.03270
(-3.44%)
0.91730 USD
A
AKBA
-0.10000
(-7.25%)
1.28000 USD
I
IMMP
-0.09500
(-4.39%)
2.07000 USD
K
KTRA
-0.00020
(-0.09%)
0.22200 USD
K
KZIA
-0.02650
(-7.10%)
0.34700 USD
L
LPTX
-0.02000
(-0.93%)
2.12000 USD
R
REKR
-0.15000
(-8.24%)
1.67000 USD
S
SLS
0.08000
(6.90%)
1.24000 USD
S
STAF
-0.02000
(-1.02%)
1.94000 USD
T
TNXP
0.00960
(1.92%)
0.51050 USD
V
VBLT
-0.01140
(-6.65%)
0.16000 USD
News

Title: Eton Pharmaceuticals

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.